new programs, Aptium is well positioned to help achieve better lives for cancer patients and their families."
Prior to joining Aptium Oncology, O'Dea held pharmacy positions with several prestigious health care institutions including nine years with the University of California, Los Angeles (UCLA). He received his Bachelor of Science in Pharmacy from the University of Connecticut in 1969. O'Dea has published and presented extensively. He is also a member of numerous professional organizations including the California Society of Health Systems Pharmacists, American Society of Health Systems Pharmacists, Health Care Executives of Southern California and the American College of Healthcare Executives, the Association of Cancer Executives, and a delegate member of the Association of Community Cancer Centers.
About Aptium Oncology
Aptium Oncology has 25 years of experience managing outpatient oncology services at leading medical institutions throughout the United States. Aptium Oncology is a pioneer in designing, building and managing comprehensive cancer centers with a steadfast vision to transform cancer care environments by bringing every necessary service to one central place. The intent of this single place is to help patients achieve longer, better lives. Aptium Oncology's corporate headquarters is located in Los Angeles, California. For more information, visit www.aptiumoncology.com.
'/>"/>SOURCE Aptium Oncology Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium2.
ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration3.
SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference4.
U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors5.
US Oncology to Report 2007 Third Quarter Earnings Results6.
VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting7.
Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines8.
Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals9.
Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting10.
Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology11.
National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative